Azelis Bundle

Who Owns Azelis?
Azelis, a major player in specialty chemicals and food ingredients, went public in September 2021. This IPO on Euronext Brussels was a significant event, valuing the company at €6.08 billion and marking a major Belgian listing.

Understanding Azelis's ownership is key to grasping its strategic direction and market influence. The company's journey from its 2001 merger to its current global standing is a testament to its growth and market positioning.
Following its IPO, Azelis's ownership structure shifted to include public shareholders. As of 2024, the company reported revenues of EUR 4,214.0 million, operating in 65 countries with over 4,300 employees. This public listing means ownership is distributed among investors who purchased shares. For a deeper dive into the company's operational environment, consider an Azelis PESTEL Analysis.
Who Founded Azelis?
Azelis was established in 2001 through the merger of Novorchem from Italy and Arnaud from France. While the specific names of the founders and their initial equity stakes are not publicly disclosed, the company's early ownership was significantly influenced by private equity firms.
Event | Year | Owner | Approximate Value |
---|---|---|---|
Merger of Novorchem and Arnaud | 2001 | Founding entities | Not Publicly Disclosed |
Acquisition of Azelis Group | 2006 | 3i | Over €300 million |
Acquisition of Azelis Group | 2015 | Funds advised by Apax Partners | Not Publicly Disclosed |
Azelis began its journey in 2001, formed by the strategic merger of Novorchem and Arnaud.
The company's initial ownership structure was heavily shaped by private equity investment.
In December 2006, 3i acquired Azelis Group for more than €300 million.
This period saw Azelis expand its operations across Europe and into Asia.
In 2015, Azelis was acquired by funds managed by Apax Partners from 3i.
These private equity transactions were key in driving Azelis's consolidation and market growth strategies.
The early ownership history of Azelis is marked by significant transitions between private equity firms, each playing a role in its strategic development and market expansion. While the specific details of the founders' initial stakes and their subsequent exits are not publicly available, these private equity buyouts were instrumental in shaping the company's trajectory, focusing on consolidating its market position and expanding its geographical reach. Understanding these early ownership changes is crucial for grasping the company's foundational growth and its subsequent journey, including its efforts to understand its Target Market of Azelis.
Azelis's ownership has been characterized by strategic acquisitions by private equity firms, driving its growth and integration.
- Formation in 2001 via merger.
- Acquisition by 3i in 2006 for over €300 million.
- Expansion into new markets under 3i's ownership.
- Acquisition by Apax Partners in 2015.
Azelis SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format

How Has Azelis’s Ownership Changed Over Time?
Azelis's ownership journey has been marked by significant private equity involvement and a pivotal transition to public trading. Initially acquired by Apax Partners in 2015, the company later transitioned to EQT Private Equity in November 2018, a period that saw substantial growth and strategic acquisitions.
Ownership Phase | Key Investor | Key Developments |
2015 - 2018 | Apax Partners | Initial acquisition by private equity |
November 2018 - Present | EQT Private Equity | Significant expansion, M&A activity, and preparation for public listing |
September 17, 2021 - Present | Publicly Traded (Euronext Brussels) | Initial Public Offering (IPO), increased financial flexibility |
The trajectory of Azelis's ownership structure has been significantly shaped by private equity backing and its subsequent public offering. EQT Private Equity's stewardship, beginning in November 2018, was instrumental in Azelis's expansion, characterized by nearly doubling its adjusted EBITA and executing 24 add-on acquisitions. This period of growth culminated in the company's listing on Euronext Brussels on September 17, 2021. The IPO raised €1.77 billion, with shares priced at €26, establishing a market capitalization of €6.08 billion. Following the IPO, EQT Private Equity, through its holding company Akita I, and co-investor Public Sector Pension Investment Board (PSP Investments), retained substantial stakes, holding approximately 51% and 12% of the shares, respectively. This transition to a publicly traded entity has enhanced Azelis's financial agility and access to capital, fueling its ongoing growth initiatives, including further strategic acquisitions. As of June 25, 2025, the free float of Azelis shares with voting rights is 71.91%, representing 175,393,211 shares. The company's financial performance, as detailed in its 2024 Integrated Report published on March 6, 2025, shows total revenue for 2024 reaching EUR 4.2 billion, with adjusted EBITA at EUR 471 million. Major institutional investors are key Azelis shareholders, as indicated by transparency notifications to the FSMA, underscoring the diverse Azelis stock ownership.
Azelis's ownership evolution highlights a strategic shift from private equity control to public market participation. The IPO in 2021 was a landmark event, significantly altering the Azelis company ownership structure.
- EQT Private Equity and PSP Investments remain significant Azelis shareholders post-IPO.
- The free float of Azelis shares stands at 71.91% as of June 25, 2025.
- The IPO in 2021 provided Azelis with substantial capital for future growth.
- Understanding who owns Azelis is crucial for assessing its strategic direction.
- The company's financial performance, with EUR 4.2 billion in revenue for 2024, influences investor interest.
- The Competitors Landscape of Azelis provides context for its market position.
Azelis PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable

Who Sits on Azelis’s Board?
The Board of Directors for Azelis is structured to provide comprehensive oversight and strategic direction. As of May 8, 2025, the board comprises both executive and non-executive members, ensuring a balance of operational knowledge and independent perspective.
Director Name | Role | Affiliation/Key Responsibility |
---|---|---|
Anna Bertona | Executive Director | Group Chief Executive Officer |
Thijs Bakker | Executive Director | Chief Financial Officer |
Kristiaan Nieuwenburg | Non-Executive Director | Partner, EQT Private Equity |
Bert Janssens | Non-Executive Director | Partner, EQT Private Equity (Led EQT's investment) |
Tom Hallam | Independent Non-Executive Director | Chair of Audit and Risk Committee |
Kåre Schultz | Independent Non-Executive Director | Chair of the Board (since 2024) |
Melanie Maas-Brunner | Independent Non-Executive Director | |
Lily Wang | Non-Executive and Independent Director | Nominated April 2025 (Subject to shareholder approval) |
The voting power within Azelis Group NV is primarily based on a one-share-one-vote principle. At the Annual General Meeting on May 8, 2025, a significant portion of the company's shares were represented, with 88.90% of all eligible shares participating. Out of a total of 243,921,719 shares outstanding, 243,510,780 shares were entitled to vote, indicating strong shareholder engagement.
The Board of Directors has established key committees to manage specific areas of corporate governance. These committees play a vital role in ensuring robust financial oversight and strategic alignment.
- The Audit and Risk Committee is chaired by Tom Hallam and includes Bert Janssens and Kåre Schultz.
- A Remuneration and Nomination Committee is also in place.
- Major shareholders, represented by EQT Private Equity partners Kristiaan Nieuwenburg and Bert Janssens, hold non-executive director positions.
- Shareholder approval is a key step in director appointments, as seen with Lily Wang's nomination.
- The Growth Strategy of Azelis is influenced by the board's decisions.
Azelis Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout

What Recent Changes Have Shaped Azelis’s Ownership Landscape?
In recent years, Azelis has seen significant shifts in its ownership structure, particularly following its initial public offering. The company has actively pursued a growth strategy through acquisitions, which has also influenced its investor base and the distribution of its shares. These developments reflect a dynamic period for Azelis as it continues to expand its global presence and market offerings.
Event | Date | Details |
---|---|---|
Sale of Shares by Akita I S.à r.L. | February 28, 2025 | Akita I S.à r.L., indirectly controlled by EQT VIII, sold 20 million shares for approximately EUR 366 million. EQT Private Equity received approximately EUR 333 million from this transaction. |
Acquisition of Solchem | April 2025 | Expansion into new markets and product segments. |
Acquisition of Haarla | November 2024 | Further diversification of Azelis's specialty chemical and food ingredient portfolio. |
Acquisition of Hortimex | October 2024 | Strengthening presence in specific geographic regions and sectors. |
Acquisition of CPS Chemicals | June 2024 | Continued integration of strategic businesses to enhance service offerings. |
Acquisition of DBH Osthandelsgesellschaft | April 2024 | Broadening the company's reach and capabilities. |
Acquisition of Marga Dwi Kencana | March 2024 | Expanding the global footprint in the specialty chemicals sector. |
Leadership Transition (Group CEO) | 2024 | Anna Bertona succeeded Dr. Hans Joachim Müller as Group CEO and joined the Board of Directors. |
Leadership Transition (Chair of the Board) | 2024 | Kåre Schultz became the Chair of the Board. |
Share Buyback Program | 2025 | 50,000 shares were bought back for over EUR 913,549.10 to satisfy LTIP obligations. |
Azelis has maintained a robust acquisition strategy over the past three to five years, completing eight acquisitions in 2024 alone, which contributed to its revenue of EUR 4,214.0 million for the year. This consistent M&A activity, averaging nearly four acquisitions annually over the last three years, underscores the company's commitment to expanding its market reach and product portfolio. As of July 2025, one acquisition has been completed in the current year, indicating the ongoing execution of this growth strategy. The company's ownership profile has also evolved, notably with the partial divestment by EQT Private Equity. In February 2025, Akita I S.à r.L., an entity indirectly controlled by EQT VIII, sold 20 million shares, generating approximately EUR 366 million in gross proceeds. This move suggests a trend where private equity investors, like EQT and PSP Investments, continue to hold significant stakes post-IPO while realizing some of their investment, potentially allowing for future strategic adjustments and continued influence. The leadership also saw a significant transition in 2024, with Anna Bertona taking over as Group CEO and Kåre Schultz assuming the role of Chair of the Board, signaling a new phase for the company's governance. Additionally, Azelis engaged in a share buyback program in 2025, repurchasing 50,000 shares to manage its incentive plans, demonstrating a focus on shareholder value and operational efficiency. The company's stated strategy emphasizes a dual approach of organic growth alongside targeted acquisitions to solidify its position as a global innovation service provider. For a deeper understanding of the company's journey, one can refer to the Brief History of Azelis.
Azelis completed eight acquisitions in 2024 and has averaged nearly four acquisitions annually over the past three years. These strategic moves are key to expanding its global footprint and service offerings.
Significant share sales by entities like Akita I S.à r.L. in early 2025 indicate a partial exit by major investors while maintaining substantial stakes. This reflects a common post-IPO trend for private equity stakeholders.
The year 2024 saw key leadership transitions, with Anna Bertona appointed Group CEO and Kåre Schultz becoming Chair of the Board. These changes mark a new chapter in the company's strategic direction.
Azelis's share buyback program in 2025, aimed at fulfilling incentive plan obligations, demonstrates a commitment to managing its capital structure and enhancing shareholder returns.
Azelis Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked

- What is Brief History of Azelis Company?
- What is Competitive Landscape of Azelis Company?
- What is Growth Strategy and Future Prospects of Azelis Company?
- How Does Azelis Company Work?
- What is Sales and Marketing Strategy of Azelis Company?
- What are Mission Vision & Core Values of Azelis Company?
- What is Customer Demographics and Target Market of Azelis Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.